The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies.
Clin Exp Rheumatol
; 31(2): 189-94, 2013.
Article
em En
| MEDLINE
| ID: mdl-23294992
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Polimorfismo Genético
/
Artrite Reumatoide
/
Fator de Necrose Tumoral alfa
/
Receptores de IgG
/
Antirreumáticos
/
Anticorpos Monoclonais Murinos
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article